BUZZ — India's Zydus Lifesciences falls after US FDA inspection ends with five observations
* Shares of pharmaceuticals company Zydus Lifesciences fell as much as 2.03% to 1,109.50 rupees * US FDA closed inspection at co's Ahmedabad manufacturing plant with five observations, co said * ZYDU closely working with FDA to address observations--statement * Stock's F12M PE ratio of 24.98 vs industry median of 25.98